VivoSim Labs Inc (VIVS)

NASDAQ
Currency in USD
1.460
+0.050(+3.55%)
Closed·
After Hours
1.450-0.010(-0.685%)
·
VIVS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
VIVS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.4301.480
52 wk Range
1.41021.960
Key Statistics
Edit
Prev. Close
1.41
Open
1.45
Day's Range
1.43-1.48
52 wk Range
1.41-21.96
Volume
43.75K
Average Volume (3m)
258.38K
1-Year Change
-84.95%
Book Value / Share
5.88
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VIVS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

VivoSim Labs Inc News & Analysis

Show more

VivoSim Labs Inc Company Profile

VivoSim Labs, Inc., a pharmaceutical and biotechnology services. Its segments include research and development R&D and Mosaic Cell Sciences. The company focuses on providing testing of drugs and drug candidates in three-dimensional 3D human tissue models of liver and intestine. Its liver testing servies such as silico liver toxicology prediction, and drug candidate screening. In addition, the company focuses on developing FXR314 in inflammatory bowel disease IBD, including ulcerative colitis UC based on demonstration of clinical promise in 3D human tissues, as well as preclinical data. The Mosaic Cell Sciences division to serve as a key source of certain primary human cells it utilizes in its research and development efforts; and 3D human tissue platform is multifaceted. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. The company was incorporated in 2007 and is headquartered in San Diego, California.

Compare VIVS to Peers and Sector

Metrics to compare
VIVS
Peers
Sector
Relationship
P/E Ratio
−1.5x−6.7x−0.5x
PEG Ratio
−0.020.030.00
Price/Book
0.4x2.3x2.6x
Price / LTM Sales
26.4x5.8x3.0x
Upside (Analyst Target)
-222.6%52.4%
Fair Value Upside
Unlock22.6%8.7%Unlock

Earnings

Latest Release
May 22, 2025
EPS / Forecast
4.21 / -2.28
Revenue / Forecast
51.00K / 46.00K
EPS Revisions
Last 90 days

VIVS Income Statement

People Also Watch

9.850
SBET
-1.50%
0.710
MLGO
-1.39%
3.950
LAES
+6.47%
4.2591
TTNP
-1.98%
1.0200
IMNN
+2.00%

FAQ

What Is the VivoSim Labs (VIVS) Stock Price Today?

The VivoSim Labs stock price today is 1.46

What Stock Exchange Does VivoSim Labs Trade On?

VivoSim Labs is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for VivoSim Labs?

The stock symbol for VivoSim Labs is "VIVS."

What Is the VivoSim Labs Market Cap?

As of today, VivoSim Labs market cap is 3.80M.

What Is VivoSim Labs's Earnings Per Share (TTM)?

The VivoSim Labs EPS (TTM) is -1.70.

From a Technical Analysis Perspective, Is VIVS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has VivoSim Labs Stock Split?

VivoSim Labs has split 3 times.

How Many Employees Does VivoSim Labs Have?

VivoSim Labs has 9 employees.

What is the current trading status of VivoSim Labs (VIVS)?

As of 21 June 2025, VivoSim Labs (VIVS) is trading at a price of 1.46, with a previous close of 1.41. The stock has fluctuated within a day range of 1.43 to 1.48, while its 52-week range spans from 1.41 to 21.96.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.